Left ventricular assist device implantation following multisystem inflammatory syndrome in children due to SARS-CoV-2

Konukoglu O., Dogan A., SEVER K., AKÇAY A., BALKANAY M., Mansuroglu D.

Journal of Cardiac Surgery, vol.37, no.11, pp.3947-3950, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 11
  • Publication Date: 2022
  • Doi Number: 10.1111/jocs.16821
  • Journal Name: Journal of Cardiac Surgery
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.3947-3950
  • Keywords: heart failure, left ventricular assist device, MIS-C, SARS-CoV-2
  • İstanbul Yeni Yüzyıl University Affiliated: Yes

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is rare, however, severe hyperinflammatory condition in children generally weeks after acute SARS-CoV-2 infection. A subset of MIS-C patients is presented with severe heart failure. We hereby report 8-year-old girl presenting acute severe left ventricular failure. Various medical treatments including inotropic agents and drugs related to SARS-CoV-2 infection and MIS-C were applied. However, venoarterial extracorporeal membrane oxygenation (ECMO) was needed to be performed. Due to unsuccessful attempts for ECMO weaning, left ventricular assist device was implanted to the patient with temporary right ventricular support from ECMO.